Latest filings (excl ownership)
8-K
Financial Statements and Exhibits
18 Apr 24
25-NSE
Exchange delisting
9 Apr 24
NT 10-K
Notice of late annual filing
29 Mar 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
13 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
8-K
Entry into a Material Definitive Agreement
16 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Dec 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Sientra Reports THIRD Quarter FINANCIAL and operational Results
9 Nov 23
8-K
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial
31 Oct 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
8-K
Sientra Reports RECORD Second Quarter FINANCIAL and operational Results
10 Aug 23
S-8
Registration of securities for employees
22 Jun 23
8-K
Departure of Directors or Certain Officers
20 Jun 23
10-Q
2023 Q1
Quarterly report
12 May 23
8-K
Sientra Reports Record First Quarter 2023 Operational Results
11 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
28 Apr 23
S-8
Registration of securities for employees
17 Apr 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
8-K
Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market with New Product Launches
30 Mar 23
8-K
Material Modifications to Rights of Security Holders
19 Jan 23
DEFA14A
Additional proxy soliciting materials
20 Dec 22
DEFA14A
Additional proxy soliciting materials
20 Dec 22
8-K
Other Events
20 Dec 22
DEFA14A
Additional proxy soliciting materials
15 Dec 22
EFFECT
Notice of effectiveness
15 Dec 22
CORRESP
Correspondence with SEC
12 Dec 22
UPLOAD
Letter from SEC
12 Dec 22
S-3
Shelf registration
5 Dec 22
DEF 14A
Definitive proxy
29 Nov 22
PRE 14A
Preliminary proxy
17 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
Sientra Reports Record Third Quarter 2022 Financial Results
10 Nov 22
8-K
Sientra Announces Proposed Public Offering
27 Oct 22
424B5
Prospectus supplement for primary offering
24 Oct 22
8-K
Other Events
20 Oct 22
Latest ownership filings
SC 13G/A
Rosalind Advisors, Inc.
20 Feb 24
SC 13G
WELLS FARGO & COMPANY/MN
6 Feb 24
4
Ronald Menezes
14 Nov 23
4
Hove Caroline F. Van
14 Nov 23
4
Oliver Christian Bennett
11 Sep 23
4
Andrew C Schmidt
7 Aug 23
4
PHILIPPE SCHAISON
20 Jun 23
4
MARY FISHER
20 Jun 23
4
Irina Erenburg
20 Jun 23
4
Nori Ebersole
20 Jun 23
4
Alexander W. Casdin
20 Jun 23
3
Alexander W. Casdin
20 Jun 23
4
Andrew C Schmidt
24 Mar 23
4
Ronald Menezes
24 Mar 23
4
Oliver Christian Bennett
24 Mar 23
SC 13G
Rosalind Advisors, Inc.
15 Feb 23
SC 13G/A
Senvest Management, LLC
10 Feb 23
4
Hove Caroline F. Van
13 Jan 23
SC 13G/A
MORGAN STANLEY
12 Dec 22
SC 13D
PESSIN NORMAN H
15 Nov 22
4
Hove Caroline F. Van
14 Nov 22
4
Ronald Menezes
14 Nov 22
4
Andrew C Schmidt
4 Aug 22
SC 13G
BlackRock Inc.
8 Jul 22
4
Keith J Sullivan
13 Jun 22
4
PHILIPPE SCHAISON
13 Jun 22
4
KEVIN C OBOYLE
13 Jun 22
4
MARY FISHER
13 Jun 22
4
Irina Erenburg
13 Jun 22
4
Nori Ebersole
13 Jun 22
4
Hove Caroline F. Van
26 May 22
4
Oliver Christian Bennett
5 May 22
SC 13D/A
Clarus Lifesciences I, L.P.
4 May 22
4
Oliver Christian Bennett
6 Apr 22
4
Andrew C Schmidt
6 Apr 22
4
Andrew C Schmidt
18 Mar 22
4
Ronald Menezes
18 Mar 22
4
Oliver Christian Bennett
18 Mar 22
SC 13G
Senvest Management, LLC
11 Feb 22
SC 13G
MORGAN STANLEY
11 Feb 22